Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2024 Earnings Call Transcript May 14, 2024
Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.41 EPS, expectations were $0.49.
Operator: Good morning, ladies and gentlemen. And welcome to the Fennec Pharmaceuticals’ First Quarter 2024 Earnings and Corporate Update Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct a question-and-answer session and instructions on how to...
